One in the eye for Illumina as Roche buys prenatal test maker
This article was originally published in Clinica
Executive Summary
Roche has acquired Ariosa Diagnostics, a privately-held US developer of blood tests used to detect Down syndrome and genetic abnormalities in the foetus.
You may also be interested in...
Illumina Awarded $26.7m In Patent Row
The verdict resolves an intellectual property dispute in which Illumina alleged Ariosa was violating Illumina's patents on prenatal genetic testing technology.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.